Joinn Laboratories China Co Ltd (603127)

Currency in CNY
31.28
-0.98(-3.04%)
Closed·
603127 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
603127 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
30.0132.16
52 wk Range
13.0237.06
Key Statistics
Bid/Ask
31.29 / 31.30
Prev. Close
32.26
Open
32.12
Day's Range
30.01-32.16
52 wk Range
13.02-37.06
Volume
40.42M
Average Volume (3m)
33.31M
1-Year Change
98.12%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603127 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
21.35
Downside
-31.75%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Joinn Laboratories China Co Ltd Company Profile

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment design, production, breeding and sales of research models, non-human primates, and rodents. The company also offers cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.

Employees
2652
Market
China

Compare 603127 to Peers and Sector

Metrics to compare
603127
Peers
Sector
Relationship
P/E Ratio
58.1x39.7x−0.5x
PEG Ratio
0.080.820.00
Price/Book
2.8x4.1x2.6x
Price / LTM Sales
11.4x5.9x3.3x
Upside (Analyst Target)
−28.9%0.5%45.1%
Fair Value Upside
Unlock5.9%7.4%Unlock

Analyst Ratings

4 Buy
3 Hold
1 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 21.35
(-31.75% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.51%
Dividend Yield
0.50%
Industry Median 0.81%
Annualised payout
0.16
Paid annually
5-Years Growth
-19.46%
Growth Streak

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
0.05 / 0.06
Revenue / Forecast
287.34M / --
EPS Revisions
Last 90 days

603127 Income Statement

FAQ

What Stock Exchange Does Joinn Laboratories China Trade On?

Joinn Laboratories China is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Joinn Laboratories China?

The stock symbol for Joinn Laboratories China is "603127."

What Is the Joinn Laboratories China Market Cap?

As of today, Joinn Laboratories China market cap is 22.99B.

What Is Joinn Laboratories China's Earnings Per Share (TTM)?

The Joinn Laboratories China EPS (TTM) is 0.51.

When Is the Next Joinn Laboratories China Earnings Date?

Joinn Laboratories China will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is 603127 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Joinn Laboratories China Stock Split?

Joinn Laboratories China has split 6 times.

How Many Employees Does Joinn Laboratories China Have?

Joinn Laboratories China has 2652 employees.

What is the current trading status of Joinn Laboratories China (603127)?

As of 04 Aug 2025, Joinn Laboratories China (603127) is trading at a price of 31.28, with a previous close of 32.26. The stock has fluctuated within a day range of 30.01 to 32.16, while its 52-week range spans from 13.02 to 37.06.

What Is Joinn Laboratories China (603127) Price Target According to Analysts?

The average 12-month price target for Joinn Laboratories China is CNY21.35, with a high estimate of CNY36.1 and a low estimate of CNY8.5. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -31.75% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.